Works matching IS 11707690 AND DT 2019 AND VI 37 AND IP 2
Results: 12
Correction to: Weight Reduction and Pioglitazone are Cost-Effective for the Treatment of Non-alcoholic Fatty Liver Disease in Thailand.
- Published in:
- 2019
- By:
- Publication type:
- corrected article
Future Costs in Cost-Effectiveness Analyses: Past, Present, Future.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Cost-Effectiveness Analysis of Direct-Acting Oral Anticoagulants for Stroke Prevention in Thai Patients with Non-Valvular Atrial Fibrillation and a High Risk of Bleeding.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Weight Reduction and Pioglitazone are Cost-Effective for the Treatment of Non-Alcoholic Fatty Liver Disease in Thailand.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Cost-Effectiveness of Herpes Zoster Vaccination: A Systematic Review.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Discrete Choice Experiments in Health Economics: Past, Present and Future.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Cost Effectiveness of Midostaurin in the Treatment of Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia in the United States.
- Published in:
- PharmacoEconomics, 2019, v. 37, n. 2, p. 239, doi. 10.1007/s40273-018-0732-4
- By:
- Publication type:
- Article
Does a Patient-Directed Financial Incentive Affect Patient Choices About Controller Medicines for Asthma? A Discrete Choice Experiment and Financial Impact Analysis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The Economic Burden of Pediatric Asthma in the United States: Literature Review of Current Evidence.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Ribociclib with an Aromatase Inhibitor for Previously Untreated, HR-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Brodalumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: An Evidence Review Group Evaluation of a NICE Single Technology Appraisal.
- Published in:
- 2019
- By:
- Publication type:
- journal article